GlassScriptPhysician profile
Timothy L Austin
NPI 1184621443
$2,980.34
in general payments reported to CMS, 2019-2025
28 companies · $544 in 2025
The $544 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $87.20 · 2021: $385 · 2022: $201 · 2023: $453 · 2024: $802 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $650.07 | 2019-2025 | Clareon, Rocklatan, Unity |
| New World Medical,INC. | $286.86 | 2023-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Abbvie INC. | $261.55 | 2022-2025 | Durysta, Alphagan P, Lumigan |
| Johnson & Johnson Surgical Vision, INC. | $237.99 | 2019-2025 | Tecnis Iol, Tecnis Iol |
| Amgen INC. | $161.95 | 2024-2025 | Tavneos, Tepezza |
| Allergan, INC. | $142.62 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $137.33 | 2019-2020 | |
| Oyster Point Pharma, INC. | $134.28 | 2022-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $131.41 | 2019 | |
| Bausch & Lomb Americas INC. | $124.04 | 2022-2025 | Vyzulta, Biotrue One Day, Infuse |
| Tarsus Pharmaceuticals, INC. | $117.59 | 2024-2025 | Xdemvy |
| Rayner Intraocular Lenses Limited | $110.86 | 2023-2024 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Sun Pharmaceutical Industries INC. | $61.32 | 2019 | |
| Sight Sciences, INC. | $51.89 | 2021-2024 | Omni Surgical System |
| Notal Vision, INC. | $45.97 | 2025 | Foresee Home |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $39.00 | 2023-2024 | Eylea, Eylea Hd |
| Biotissue Holdings INC. | $37.08 | 2022-2023 | |
| Shire North American Group INC | $33.15 | 2019 | |
| Ocular Therapeutix, INC. | $32.10 | 2021 | |
| Gilead Sciences, INC. | $25.17 | 2022 | |
| Rxsight INC | $24.84 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $22.45 | 2025 | Vevye |
| Genentech USA, INC. | $21.62 | 2023 | Vabysmo |
| Mallinckrodt Enterprises LLC | $19.79 | 2019 | |
| Dompe US, INC. | $19.18 | 2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $18.80 | 2019 | |
| Glaukos Corporation | $16.92 | 2024 | Radius |
| Lumenis, INC | $14.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.